TLM Utility Nav

AASLD/SITC Joint Course: The Present and Future State of Immune Therapy and Care Delivery For Liver Cancer

Description

Multidisciplinary care is essential for the optimal management of patients with liver cancer. Hepatologists play a central role in liver cancer care by assessing and managing underlying liver disease. Skills unique to hepatology include stratifying severity of liver disease, identifying and managing portal hypertension, understanding liver metabolism, and managing liver related toxicity of immune and other oncologic therapies.
The overall goal of this program is to introduce and discuss novel paradigms of HCC management and the integration of hepatology into the systemic therapy of HCC. In the first session, we will explore European and Asian models of care delivery, assess the current state of systemic therapies, consider real-world application of clinical trials data to complex cases, and understand how to anticipate and manage side effects of systemic therapy.

Presentations

8:00 AM - 8:03 AM
Nov 18 2024
San Diego, CA

Introduction

Tamar Taddei, MD, MD, FAASLD, Moderator
8:03 AM - 8:18 AM
Nov 18 2024
San Diego, CA

Current landscape of systemic treatments, incl. patient monitoring and adverse events

Mark Yarchoan, Presenter
8:18 AM - 8:33 AM
Nov 18 2024
San Diego, CA

Systemic Therapy in a Multidisciplinary Management Setting – The Role of a Hepatologist 

Tim F Greten, Presenter
8:33 AM - 8:48 AM
Nov 18 2024
San Diego, CA

Liver Dysfunction following Systemic Therapy for HCC 

Anjana Pillai, MD, FAASLD, Presenter
8:48 AM - 8:58 AM
Nov 18 2024
San Diego, CA

Alternate Care Models - China

Andrew X Zhu, MD, PhD, Presenter
8:58 AM - 9:08 AM
Nov 18 2024
San Diego, CA

Alternate Care Models - Japan

Masatoshi MK Kudo, MD, PhD, Presenter
9:08 AM - 9:18 AM
Nov 18 2024
San Diego, CA

Alternate Care Models - Latin America

Federico Piñero, MD, Msc, PhD, Presenter
9:18 AM - 9:30 AM
Nov 18 2024
San Diego, CA

Q&A/Panel Discussion - All Presenters

Tamar Taddei, MD, MD, FAASLD, Moderator

Objectives

  • Learn about the global diversity of HCC care delivery practices
  • Describe the currently available systemic therapies for treating patients with HCC and real-world approaches to complex cases
  • Identify and manage immune related adverse effects of immune therapies
Chair

Neehar D. Parikh, MD, MS, FAASLD

University of Michigan Medical Center